Redx Pharma Ltd

5 clinical trials · Sponsor

Record	Firm	Date
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis (NCT05570058)	Redx Pharma Ltd	2022-09-08
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (NCT04907851)	Redx Pharma Ltd	2021-12-10
A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers (NCT04931147)	Redx Pharma Ltd	2021-05-13
Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies (NCT03447470)	Redx Pharma Ltd	2019-03-18

Every clearance here is in the API, with alerts when new ones post.